SI
Silo Pharma, Inc.
SILO · NASDAQ
$1.84 +10.18% (+$0.17)
1M -28.68%
Market Cap $2.08M
P/E Ratio -
Div. Yield -
ROE 81.74%
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/B 0.42x
P/S 38.40x
EV/EBITDA N/A
Growth
16 /100
Declining Book val. growth 15.20%
Rev. growth 0.00%
FCF growth N/A
Profitability
0 /100
Weak Net margin 8,269.53%
Op. margin 8,250.46%
FCF margin 6,176.84%
Quality
0 /100
Poor ROE 81.74%
ROA 75.13%
Asset turnover 0.01x
Debt
69 /100
Low Current ratio 5.36x
Int. coverage -115.27x
Debt/Equity 0.00x
Stability
76 /100
Stable Rev. volatility 0.00%
EPS volatility 28.58%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SILO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Eric Weisblum
Employees
3
Headquarters
Sarasota
Upcoming events
02 DEC
Earnings
Upcoming earnings report